info
Thank you for visiting CancerPPD.

Browse Result page of CancerPPD


This page gives details of Query peptides and provides facility to browse the same in CancerPPD database. Please wait while data is being retrieved. For more information see HELP page.




IDPMIDSEQUENCENAME LENGTHACTIVITY
1907NoneFALAFLAK-120B4LD50 =>1000 µg/ml
2059NoneFALAFLAK-120B4LD50 =>1000 µg/ml
2211NoneFALAFLAK-120B4LD50 =>1000 µg/ml
2363NoneFALAFLAK-120B4LD50 =>1000 µg/ml
2516NoneFALAFLAK-120B4LD50 =>1000 µg/ml
2659NoneFALAFLAK-120B4LD50 =>1000 µg/ml
2802NoneFALAFLAK-120B4LD50 = >1000 µg/ml
284515634655ERRPEGFR-related peptide430% Cell viability at 5 µg/ml
287223583573DEVDcaspase 3 inhibitor465% Cell viability at 20 µM
287323583573DEVDcaspase 3 inhibitor440% Cell viability at 30 µM
287423583573DEVDcaspase 3 inhibitor435 % Cell viability at 40 µM
318917787026(K-Aib-C(CH2CO-2'-Pac))2Dimer of peptide-paclitaxel conjugate3IC50 =1.31nM
319017787026(K-Aib-C(CH2CO-2'-Pac))3Dimer of peptide-paclitaxel conjugate3IC50 =2.85nM
319117787026(K-Aib-C(CH2CO-2'-Pac))4Dimer of peptide-paclitaxel conjugate3IC50 =0.62nM
319217787026(K-Aib-C(CH2CO-2'-Pac))3Trimer of peptide-paclitaxel conjugate3IC50 =1.70nM
319317787026(K-Aib-C(CH2CO-2'-Pac))3Trimer of peptide-paclitaxel conjugate3IC50 =3.88nM
319417787026(K-Aib-C(CH2CO-2'-Pac))3Trimer of peptide-paclitaxel conjugate3IC50 =3.00nM
319517787026(K-Aib-C(CH2CO-2'-Pac))4Tetramer of peptide-paclitaxel conjugate3IC50 =0.96nM
319617787026(K-Aib-C(CH2CO-2'-Pac))4Tetramer of peptide-paclitaxel conjugate3IC50 =1.30nM
319717787026(K-Aib-C(CH2CO-2'-Pac))4Tetramer of peptide-paclitaxel conjugate3IC50 =0.64nM
334223533710YPFPGβ-Casomorphins 5 f(60_64)4Inhibition at 9-11g/l
334522820149Structure GivenBAA-1Not AvailableIC50 = 8.1 µg/ml
334622820149Structure GivenBAA-2Not AvailableIC50 = 3.8 µg/ml
334711943716Not AvailableHα-Defensin HNPs-1Not AvailableInhibition at 12.5 µg/ml
334811943716Not AvailableHα-Defensin HNPs-2Not AvailableInhibition at 12.5 µg/ml
334911943716Not AvailableHα-Defensin HNPs-3Not AvailableInhibition at 12.5 µg/ml
37192387772I-C28H46N4O6, II-C27H44N4O6, III-C26H42N4O6Cepafungin complexNot AvailableNA
384716722632YA*8214.2% inhibition at 10-6
384816722632YA*8219.7% inhibition at 10-5
384916722632YA*8224.9% inhibition at 10-4
385016722632YA*8230.4% inhibition at 10-3
385116722632YA*8210% inhibition at 10-5
385216722632YA*828.2% inhibition at 10-4
385316722632YA*8236.1% inhibition at 10-3
385416722632YA*826.5% inhibition at 10-6
385516722632YA*8214% inhibition at 10-5
385616722632YA*827.5% inhibition at 10-4
385716722632YA*8214% inhibition at 10-3
385816722632YA*829.8% inhibition at 10-6
385916722632YA*821.6% inhibition at 10-5
386016722632YA*825.4% inhibition at 10-4
386116722632YA*8226.5% inhibition at 10-3
386216722632YA*8212.9% inhibition at 10-6
386316722632YA*8216.5% inhibition at 10-5
386416722632YA*8228.1% inhibition at 10-4
386516722632YA*8258.2% inhibition at 10-3
386616722632YA*823.5% inhibition at 10-6
386716722632YA*8222.7% inhibition at 10-5
386816722632YA*8218.9% inhibition at 10-4
386916722632YA*8226.4% inhibition at 10-3
387016722632YA*822.4% inhibition at 10-5
387116722632YA*827.5% inhibition at 10-4
387216722632YSA*936.2% inhibition at 10-6
387316722632YSA*936.4% inhibition at 10-5
387416722632YSA*938.2% inhibition at 10-4
387516722632YSA*9321.2% inhibition at 10-3
387616722632YSA*937.5% inhibition at 10-6
387716722632YSA*936.1% inhibition at 10-5
387816722632YSA*933.1% inhibition at 10-4
387916722632YSA*9314.8% inhibition at 10-3
388016722632YSA*933.9% inhibition at 10-5
388116722632YSA*937.3% inhibition at 10-3
388216722632YSA*934.9% inhibition at 10-6
388316722632YSA*938.9% inhibition at 10-5
388416722632YSA*933.4% inhibition at 10-4
388516722632YSA*9320.8% inhibition at 10-3
388616722632YSA*9310.5% inhibition at 10-6
388716722632YSA*9321.9% inhibition at 10-5
388816722632YSA*9311.8% inhibition at 10-4
388916722632YSA*9317.9% inhibition at 10-3
389016722632YSA*933.7% inhibition at 10-6
389116722632YSA*9316.5% inhibition at 10-5
389216722632YSA*938.4% inhibition at 10-4
389316722632YSA*9314.5% inhibition at 10-3
389416722632YSA*931.1% inhibition at 10-5
389516722632YSA*931.2% inhibition at 10-4
389616722632YSA*9317.8% inhibition at 10-3
389716722632YSA*1038.5% inhibition at 10-6
389816722632YSA*1034.9% inhibition at 10-5
389916722632YSA*1031.9% inhibition at 10-4
390016722632YSA*10316.2% inhibition at 10-3
390116722632YSA*1037.2% inhibition at 10-6
390216722632YSA*10317.1% inhibition at 10-5
390316722632YSA*10311.0% inhibition at 10-4
390416722632YSA*10320.5% inhibition at 10-3
390516722632YSA*1033.0% inhibition at 10-6
390616722632YSA*1034.7% inhibition at 10-5
390716722632YSA*1032.7% inhibition at 10-4
390816722632YSA*1037.3% inhibition at 10-3
390916722632YSA*1030.7% inhibition at 10-6
391016722632YSA*1038.3% inhibition at 10-5
391116722632YSA*10310.5% inhibition at 10-4
391216722632YSA*10321.8% inhibition at 10-3
391316722632YSA*10310.7% inhibition at 10-6
391416722632YSA*10310.0% inhibition at 10-5
391516722632YSA*1037.7% inhibition at 10-4M
391616722632YSA*10318.7% inhibition at 10-3M
391716722632YSA*G1542.7% inhibition at 10-6M
391816722632YSA*G1542.0% inhibition at 10-5M
391916722632YSA*G15418.8% inhibition at 10-4M
392016722632YSA*G15426.7% inhibition at 10-3M
392116722632YSA*G1549.8% inhibition at 10-6M
392216722632YSA*G1547.3% inhibition at 10-5M
392316722632YSA*G1549.9% inhibition at 10-4M
392416722632YSA*G15428.2% inhibition at 10-3M
392516722632YSA*G1541.6% inhibition at 10-6M
392616722632YSA*G1542.9% inhibition at 10-5M
392716722632YSA*G1545.9% inhibition at 10-4M
392816722632YSA*G15417.9% inhibition at 10-3M
392916722632YSA*G1545.4% inhibition at 10-6M
393016722632YSA*G1547.4% inhibition at 10-5M
393116722632YSA*G1549.5% inhibition at 10-4M
393216722632YSA*G15415.7% inhibition at 10-3M
393316722632YSA*G15413.6% inhibition at 10-6M
393416722632YSA*G15420.4% inhibition at 10-5M
393516722632YSA*G15414.4% inhibition at 10-4M
393616722632YSA*G15423.4% inhibition at 10-3M
393716722632YSA*G1542.2% inhibition at 10-6M
393816722632YSA*G1544.2% inhibition at 10-5M
393916722632YSA*G1546.4% inhibition at 10-4M
394016722632YSA*G1546.2% inhibition at 10-3M
394116722632YSA*G15421.2% inhibition at 10-3M
394216722632YRA*G1644.6% inhibition at 10-6M
394316722632YRA*G1644.9% inhibition at 10-5M
394416722632YRA*G16412.6% inhibition at 10-4M
394516722632YRA*G16426.4% inhibition at 10-3M
394616722632YRA*G16411.0% inhibition at 10-6M
394716722632YRA*G16411.7% inhibition at 10-5M
394816722632YRA*G16411.6% inhibition at 10-4M
394916722632YRA*G16428.2% inhibition at 10-3M
395016722632YRA*G1641.2% inhibition at 10-5M
395116722632YRA*G1643.3% inhibition at 10-4M
395216722632YRA*G16419.4% inhibition at 10-3M
395316722632YRA*G1647.6% inhibition at 10-6M
395416722632YRA*G1643.8% inhibition at 10-5M
395516722632YRA*G16412.4% inhibition at 10-4M
395616722632YRA*G16422.4% inhibition at 10-3M
395716722632YRA*G16417.0% inhibition at 10-6M
395816722632YRA*G16413.5% inhibition at 10-5M
395916722632YRA*G16413.5% inhibition at 10-4M
396016722632YRA*G16425.3% inhibition at 10-3M
396116722632YRA*G1648.1% inhibition at 10-6M
396216722632YRA*G1646.9% inhibition at 10-5M
396316722632YRA*G1648.1% inhibition at 10-4M
396416722632YRA*G1648.6% inhibition at 10-3M
396516722632YRA*G16415.6% inhibition at 10-3M
419915835725lwPsychrophilin D (1)Not AvailableID50=10.1 µg/ml
421815887970Not AvailableSansalv amide ANot AvailableEC50=7.5 µM
421916091933YSLTyroserleutide349.4% cytotoxic at 0.1 µg/ml
422016091933YSLTyroserleutide351.2% cytotoxic at 1 µg/ml
422116091933YSLTyroserleutide353.0% cytotoxic at 10 µg/ml
422216091933YSLTyroserleutide361.2% cytotoxic at 100 µg/ml
422316091933YSLTyroserleutide339.0% cytotoxic at 0.1 µg/ml
422416091933YSLTyroserleutide320.8% cytotoxic at 1 µg/ml
422516091933YSLTyroserleutide333.8% cytotoxic at 10 µg/ml
422616091933YSLTyroserleutide335.6% cytotoxic at 100 µg/ml
46408445676VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline		Dolastatin 15Not AvailableIC50=.00013-.0013 nM
46418445676VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline		Dolastatin 15Not AvailableIC50=.00013-.0013 nM
46428445676VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline		Dolastatin 15Not AvailableIC50=.00013-.0013 nM
46438445676VV-Nme-VPP-2-hydroxyisovaleryl-2-
oxo-4-methoxy-5-benzyl-3-pyrroline		Dolastatin 15Not AvailableIC50=.00013-.0013 nM
464484456762-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide		Dolastatin 10Not AvailableIC50=.0013-.013 nM
464584456762-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide		Dolastatin 10Not AvailableIC50=.0013-.013 nM
464684456762-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide		Dolastatin 10Not AvailableIC50=.00013-.0013 nM
464784456762-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-
(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-
1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-
dimethylbutanamide		Dolastatin 10Not AvailableIC50=.0013-.013 nM
464823085771Not Available5a3IC50=10.6 µM
464923085771Not Available5b3IC50=7.1 µM
465023085771Not Available5c3IC50=4.1 µM
465123085771Not Available6a3IC50=14.4 µM
465223085771Not Available6b3IC50=11.0 µM
465323085771Not Available6c3IC50=4.3 µM
465423085771Not Available7a3IC50=>63 µM
465523085771Not Available7b3IC50=>78 µM
465623085771Not Available7c3IC50=79 µM
465723085771Not Available8a3IC50=136 µM
465823085771Not Available8b3IC50=>254 µM
465923085771Not Available8c3IC50=107 µM
466023085771Not Available9a3IC50=31 µM
466123085771Not Available9b3IC50=2.3 µM
466223085771Not Available9c3IC50=3.1 µM
466323085771Not Available10a3IC50=28 µM
466423085771Not Available10b3IC50=11.4 µM
466523085771Not Available10c3IC50=6.6 µM
466623085771Not Available11a3IC50=5.2 µM
466723085771Not Available11b3IC50=19 µM
466823085771Not Available11c3IC50=7.2 µM
466923085771Not Available12a3IC50=6.1 µM
467023085771Not Available12b3IC50=27 µM
467123085771Not Available12c3IC50=14 µM
467594928452-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-
[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-
1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-
yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide		Dolastatin 10Not AvailableIC50=0.5 nM